Seer Inc News - SEER

Professional-Grade Tools, for Individual Investors.

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549_____________________________SCHEDULE 14APROXY STATEMENT PURSUANT TO SECTION...

Proxy Statement (definitive) (def 14a)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549_____________________________SCHEDULE 14APROXY STATEMENT PURSUANT TO SECTION...

Seer to Report First Quarter 2023 Financial Results on May 9, 2023

REDWOOD CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company...

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549_____________________________SCHEDULE 14APROXY STATEMENT PURSUANT TO SECTION...

Seer’s Proteograph™ Product Suite identifies undiscovered links between protein variants and lung cancer progression

REDWOOD CITY, Calif., March 29, 2023 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company...

Securities Registration: Employee Benefit Plan (s-8)

As filed with the Securities and Exchange Commission on March 8, 2023 Registration No. 333- UNITED STATESSECURITIES...

Annual Report (10-k)

00017264452022FYFalseP1YP2Y00017264452022-01-012022-12-3100017264452022-06-30iso4217:USD0001726445us-gaap:Common...

Seer Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Outlook

REDWOOD CITY, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company...

Seer to Present at the Cowen 43rd Annual Health Care Conference

REDWOOD CITY, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange...

Schedule 13g
(sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange...

Seer to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023

REDWOOD CITY, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company...

Amended Statement of Ownership (sc 13g/a)

SCHEDULE 13G Amendment No.2 SEER INC CLASS A COMMON STOCK Cusip #81578P106 Check the appropriate box to designate the...

Amended Statement of Ownership (sc 13g/a)

SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934(Amendment No.: 1)* Name...

Monksdream 1 week ago

SEER under $2

👍️0

Monksdream 3 weeks ago

SEER under $2

👍️0

Monksdream 3 months ago

SEER under $2

👍️0

Monksdream 4 months ago

SEER under $2

👍️0

Monksdream 5 months ago

SEER under $2

👍️0

Monksdream 9 months ago

SEER new 52 week low

👍️0

Monksdream 9 months ago

SEER under $2

👍️0

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Seer Inc (SEER)

Professional-Grade Tools, for Individual Investors.

SEER News

Additional Proxy Soliciting Materials (definitive) (defa14a)

Proxy Statement (definitive) (def 14a)

Seer to Report First Quarter 2023 Financial Results on May 9, 2023

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

Seer’s Proteograph™ Product Suite identifies undiscovered links between protein variants and lung cancer progression

Securities Registration: Employee Benefit Plan (s-8)

Annual Report (10-k)

Seer Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Outlook

Seer to Present at the Cowen 43rd Annual Health Care Conference

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Schedule 13g
(sc 13g)

Seer to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

SEER Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Seer Inc (SEER) News

Seer Inc (SEER)

Professional-Grade Tools, for Individual Investors.

SEER News

Additional Proxy Soliciting Materials (definitive) (defa14a)

Proxy Statement (definitive) (def 14a)

Seer to Report First Quarter 2023 Financial Results on May 9, 2023

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

Seer’s Proteograph™ Product Suite identifies undiscovered links between protein variants and lung cancer progression

Securities Registration: Employee Benefit Plan (s-8)

Annual Report (10-k)

Seer Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Outlook

Seer to Present at the Cowen 43rd Annual Health Care Conference

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Schedule 13g (sc 13g)

Seer to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

SEER Discussion

Your Recent History

Schedule 13g
(sc 13g)